Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research

by Gimotty, Phyllis A., Zhang, Lin, Alagkiozidis, Ioannis, Cadungog, Mark, Adams, Sarah, Chu, Christina, Katsaros, Dionysios, Coukos, George
Published 2007

Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer

by Holtz, David O, Krafty, Robert T, Mohamed-Hadley, Alisha, Zhang, Lin, Alagkiozidis, Ioannis, Leiby, Benjamin, Guo, Wensheng, Gimotty, Phyllis A, Coukos, George
Published 2008

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation

by Kumar, Suresh M., Liu, Shujing, Lu, Hezhe, Zhang, Hongtao, Zhang, Paul J., Gimotty, Phyllis A., Guerra, Matthew, Guo, Wei, Xu, Xiaowei
Published 2012

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia

by Sloan, Caroline E., Luskin, Marlise R., Boccuti, Anne M., Sehgal, Alison R., Zhao, Jianhua, Daber, Robert D., Morrissette, Jennifer J. D., Luger, Selina M., Bagg, Adam, Gimotty, Phyllis A., Carroll, Martin
Published 2016

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor suppressor activities

by Kagawa, Shingo, Natsuizaka, Mitsuteru, Whelan, Kelly A., Facompre, Nicole, Naganuma, Seiji, Ohashi, Shinya, Kinugasa, Hideaki, Egloff, Ann Marie, Basu, Devraj, Gimotty, Phyllis A., Klein-Szanto, Andres J, Bass, Adam, Wong, Kwok-Kin, Diehl, J. Alan, Rustgi, Anil K., Nakagawa, Hiroshi
Published 2014